itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Meet LangGraph Multi-Agent Swarm: A Python Library for Creating Swarm-Style Multi-Agent Systems Using LangGraph

    16 мая, 2025

    «`html Meet LangGraph Multi-Agent Swarm: A Python Library for Creating Swarm-Style Multi-Agent Systems Using LangGraph LangGraph Multi-Agent Swarm is a Python library designed to orchestrate multiple AI agents as a cohesive “swarm.” It builds on LangGraph, a framework for constructing robust, stateful agent workflows, enabling a specialized form of multi-agent architecture. In a swarm, agents… →

    AI News
  • DanceGRPO: A Unified Framework for Reinforcement Learning in Visual Generation Across Multiple Paradigms and Tasks

    16 мая, 2025

    «`html DanceGRPO: A Unified Framework for Reinforcement Learning in Visual Generation Across Multiple Paradigms and Tasks Recent advancements in generative models, particularly diffusion models and rectified flows, have significantly improved visual content creation. Integrating human feedback during training is crucial for aligning outputs with human preferences and aesthetic standards. However, current methods, such as ReFL,… →

    AI News
  • Managing Supply Chains in a Tariff-Fueled Trade War

    16 мая, 2025

    Alice Mollon/Ikon Images Companies routinely retune their supply chains in response to market changes, but the gyrations caused by the Trump administration’s on/off tariff regime are far from routine. How do supply chain planners address the immediate challenges, and what are the long-term implications they should consider? Many larger companies can cope with the new… →

    Management
  • ByteDance Introduces Seed1.5-VL: A Vision-Language Foundation Model Designed to Advance General-Purpose Multimodal Understanding and Reasoning

    15 мая, 2025

    «`html ByteDance Introduces Seed1.5-VL: A Vision-Language Foundation Model ByteDance has developed Seed1.5-VL, a vision-language foundation model that integrates visual and textual data to enhance multimodal understanding and reasoning. This model is designed to address the limitations of current Vision-Language Models (VLMs) in tasks requiring complex reasoning and interaction in both digital and real-world environments. Advancements… →

    AI News
  • Comparison of two maneuvers to identify Carnett’s sign in patients with chronic abdominal pain. Randomized controlled clinical trial

    15 мая, 2025

    CONCLUSION: The two ways of exploring the Carnett sign have similar efficacy. Infiltration with 2% lidocaine produced rapid and significant improvement of pain with minimal side effects. Not knowing the Carnett sign increases health costs. →

    Clinical Trials
  • Anaerobutyricum soehngenii improves glycemic control and other markers of cardio-metabolic health in adults at risk of type 2 diabetes

    15 мая, 2025

    Anaerobutyricum soehngenii (previously Eubacterium hallii) is a butyrate-producing next-generation beneficial microbe generally recognized as safe. Several short-term intervention trials by A. soehngenii L2-7 have shown improvement of insulin sensitivity in prediabetic subjects and type 2 diabetes patients. To determine the long-term cardiometabolic benefits and safety, we performed a 3-month double-blind, randomized placebo-controlled intervention in 98… →

    Clinical Trials
  • Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial

    15 мая, 2025

    CONCLUSION: Efepoetin alfa demonstrated non-inferiority to methoxy polyethylene glycol-epoetin beta in correcting anaemia and maintaining haemoglobin (Hb) levels among stage 3 and 4 CKD patients. Moreover, the safety profile of efepoetin alfa was comparable to methoxy polyethylene glycol-epoetin beta. →

    Clinical Trials
  • Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab

    15 мая, 2025

    CONCLUSIONS: WBC ≥ 70 × 10⁹/L is a high-risk feature in patients with Ph + ALL receiving frontline blinatumomab and ponatinib and may supersede the prognostic importance of baseline molecular features. Alternative frontline treatment strategies may be needed for these patients to reduce the risk of relapse and improve long-term outcomes. →

    Clinical Trials
  • Synergistic Enhancement of Compromised Skin Radiance: A Clinical Investigation of Prinsepia utilis Royle Polysaccharides and Nonapeptide Co-Application

    15 мая, 2025

    CONCLUSION: PCA analysis revealed PUR9-2 uniquely modulated gene expression compared to PURP and EQ9. Functional enrichment analysis based on Gene Ontology (GO) demonstrated PUR9-2 restored UVA-suppressed TNFAIP3 and CRNN gene. The results of RT-PCR also indicated that PUR9-2 enhanced skin barrier integrity in 3D models via upregulated expression of FLG, LOR, and DSG1. The Chou-Talalay… →

    Clinical Trials
  • What GenAI Tools Can and Can’t Do for Presentations

    15 мая, 2025

    Carolyn Geason-Beissel/MIT SMR | Getty Images As generative AI emerges as an easy way to perform computer-generated research, writing, and editing all in one fell swoop, it’s tempting to marvel at how it might improve one of the harder parts of leadership: creating convincing presentations to sell ideas to various constituencies. We’re entering a new… →

    Management
Предыдущая страница
1 … 329 330 331 332 333 … 969
Следующая страница